Skip to main content

Insights

Strategic perspectives, visions, interviews and analyses by our leadership team. A window into the thinking that drives innovation, covering governance, sustainability and new directions for decentralised molecular diagnostics.

Editorial Manifesto

20 August 2025 | Market and Industry Trends

Personalised medicine: potential and investment for the healthcare of the future

Personalised medicine replaces the “one-size-fits-all” model with tailored treatments based on genetic and molecular profiles. The article shows how multiplex diagnostics—decentralised, modular and integrable—enable faster and more sustainable treatment pathways, with Ulisse Biomed as the infrastructure enabler.

10 August 2025 | Microbiota between Diagnostics and Nutraceuticals

Gut microbiota testing: PCR innovations

Modular qPCR testing quantifies Akkermansia, Faecalibacterium, Lactobacillus and Bifidobacterium within hours, enabling customised pathways and Diagnostics as a Service models.

01 August 2025 | Biotech and Diagnostic Innovation

Decentralised Real-Time PCR for respiratory diseases

Decentralised molecular diagnostics are revolutionising the rapid identification of respiratory infections. Thanks to portable multiplex real-time PCR systems, it is now possible to obtain accurate diagnoses of influenza, RSV, SARS-CoV-2 and other diseases on-site, optimising reporting times and supporting timely clinical decisions.

10 July 2025 | Distributed Diagnostics

Molecular diagnostics: centralised vs. distributed models compared

Core Lab or Point-of-Care? True innovation is in the synergy. A reasoned comparison of two complementary architectures of modern diagnostics.

01 July 2025 | Biotech and Diagnostic Innovation

The Ulisse Biomed Ecosystem: the Hyris System™ modular diagnostic platform

The Hyris System™ ecosystem from Ulisse Biomed combines portable hardware, cloud software and advanced reagents in a modular and scalable platform.

20 June 2025 | Biotech and Diagnostic Innovation

Cloud Diagnostics Analytics: trends and applications

The future of diagnostics is cloud-based. CDA revolutionises laboratory workflows and creates strategic value from every data point.

10 June 2025 | Vision & Strategy

Innovation and sustainability in molecular diagnostics

Innovation only has value if it is also sustainable. Ulisse Biomed makes this a guiding principle, combining AI, cloud technology and decentralisation.

01 June 2025 | Microbiota between Diagnostics and Nutraceuticals

Microbiota: what it is and why it is important

The microbiota is an invisible ecosystem that is crucial to our health. This article explores its fundamentals, functions and diagnostic value.

20 May 2025 | Vision & Strategy

Inside innovation: paths, people and vision of R&D at Ulisse Biomed

What lies behind innovation at Ulisse Biomed? Three interviews reveal the method, vision and culture of R&D.

10 May 2025 | Biotech and Diagnostic Innovation

Artificial intelligence in PCR diagnostics

The artificial intelligence embedded in the Hyris™ system is transforming PCR into a predictive and distributed platform.

01 May 2025 | Market and Industry Trends

Decentralised Diagnostics: Growth and Future of the Market

Decentralised diagnostics is growing in double figures, driven by portable PCR, DaaS and AI models. That is why it is the trend to watch by 2030.

20 April 2025 | Biotech and Diagnostic Innovation

What is PCR - Basics of molecular biology

PCR is the technique that revolutionised molecular diagnostics. This article explains the basics in a clear and professional manner.

10 April 2025 | Vision & Strategy

Ulisse Biomed / New editorial project

A new editorial section to read the future of molecular diagnostics through vision, method and authoritative content.